Identifying tumor immunity-associated molecular features in liver hepatocellular carcinoma by multi-omics analysis

Background: Although current immunotherapies have achieved some successes for hepatocellular carcinoma (HCC) patients, their benefits are limited for most HCC patients. Therefore, the identification of biomarkers for promoting immunotherapeutic responses in HCC is urgently needed. Methods: Using the...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Qianyun, He, Yin, Qian, Jiajie, Wang, Xiaosheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632276/
https://www.ncbi.nlm.nih.gov/pubmed/36339710
http://dx.doi.org/10.3389/fmolb.2022.960457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632276/
https://www.ncbi.nlm.nih.gov/pubmed/36339710
http://dx.doi.org/10.3389/fmolb.2022.960457

Ejemplares similares